Skip to Content

ULTRA Hybrid FVRCP

This page contains information on ULTRA Hybrid FVRCP for veterinary use.
The information provided typically includes the following:
  • ULTRA Hybrid FVRCP Indications
  • Warnings and cautions for ULTRA Hybrid FVRCP
  • Direction and dosage information for ULTRA Hybrid FVRCP

ULTRA Hybrid FVRCP

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Feline Rhinotracheitis-Calici-Panleukopenia Vaccine

Modified Live & Killed Virus

Veterinary Use Only

For subcutaneous vaccination of healthy cats 8 weeks of age or older as an aid in the prevention of disease caused by feline rhinotracheitis, feline calicivirus (FCV), and panleukopenia viruses. This vaccine contains two feline calicivirus strains and has been shown to induce a cross-neutralizing antibody response against multiple FCV isolates obtained from diverse locales across the United States.

Directions For Use

General directions: Aseptically rehydrate this product with the accompanying sterile diluent. Inject one 0.5 mL dose subcutaneously using aseptic technique. Do not vaccinate pregnant queens.

Primary vaccination: Cats should receive two doses 3 to 4 weeks apart. Kittens should be vaccinated every 3 to 4 weeks until at least 12 weeks of age. Completion of kitten primary immunization series at 14 to 16 weeks should be considered.

Annual vaccination: Annual revaccination with a single dose is recommended.

Storage

Store in the dark at 2° to 7°C (35° to 45°F). Avoid freezing. Shake well. Burn container and all unused contents. In case of anaphylactoid reaction, administer epinephrine.

● Non-Adjuvanted

Thimerosal, neomycin and polymyxin B added as preservatives.

ULTRA Hybrid FVRCP Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

Patent Pending

© 2016 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506 U.S.A.

US Vet. Lic. No. 124

25 Doses

25 Vials of Vaccine plus 25 x 0.5 mL Vials of Diluent

CPN: 1028304.0

BOEHRINGER INGELHEIM VETMEDICA, INC.
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
Telephone:   800-325-9167
Fax:   816-236-2717
Website:   www.bevaccinesmart.com
    www.bi-vetmedica.com
    www.biviultraduramune.com
    www.bividollarsandsense.com
    www.bronchi-shieldoral.com
    www.duramunelepto.com
    www.duramunelyme.com
    www.haveweseenyourcatlately.com
    www.metacam.com
    www.mycathasdiabetes.com
    www.productionvalues.us
    www.prrsresearch.com
    www.prozinc.us
    www.vetera-vaccines.com
    www.vetmedin-us.com
    www.yourdogsheart.com
Email:   info@productionvalues.us
Every effort has been made to ensure the accuracy of the ULTRA Hybrid FVRCP information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-10-31

Hide